Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Retinoblastoma epidemiology and demographics

Introduction

Overview

Overview

The incidence of retinoblastoma in the United States has been reported to be 1.2 cases per 100,000 children aged 4 years or younger. The median age at diagnosis of retinoblastoma is 18 months. The average age at diagnosis of retinoblastoma for children with unilateral disease and bilateral disease is 24 months and 12 months respectively. Retinoblastoma affects males and females equally. There is no racial predilection to the development of retinoblastoma.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • The incidence of retinoblastoma in the United States has been reported to be 1.2 cases per 100,000 children aged 4 years or younger.[1]
  • The tumor incidence has been reported 0.049 cases per 100,000 child aged 5 to 9.

Prevalence

  • There is no data on the prevalence of retinoblastoma.

Case-fatality rate/Mortality rate

Age

Gender

Race

  • There is no racial predilection to the development of retinoblastoma.[5]

Region

Country Incidence
Mali 4.25
Uganda 2.4
Zimbabwe 2.33
Hawaii 2.25
India 1.96
Vietnam 1.89
Singapore 1.88
New Zealand 1.78 – 1.86
Spain 1.78
Philippines 1.74
Colombia 1.71
Ecuador 1.66
Nigeria 1.61
Costa Rica 1.57
Peru 1.55
References

References

  1. ↑ Fernandes, Arthur Gustavo; Pollock, Benjamin D.; Rabito, Felicia A. (2018). “Retinoblastoma in the United States: A 40-Year Incidence and Survival Analysis”. Journal of Pediatric Ophthalmology & Strabismus. 55 (3): 182–188. doi:10.3928/01913913-20171116-03. ISSNΒ 0191-3913.
  2. ↑ Dimaras, Helen; Kimani, Kahaki; Dimba, Elizabeth AO; Gronsdahl, Peggy; White, Abby; Chan, Helen SL; Gallie, Brenda L (2012). “Retinoblastoma”. The Lancet. 379 (9824): 1436–1446. doi:10.1016/S0140-6736(11)61137-9. ISSNΒ 0140-6736.
  3. ↑ Kim, J W; Kathpalia, V; Dunkel, I J; Wong, R K; Riedel, E; Abramson, D H (2008). “Orbital recurrence of retinoblastoma following enucleation”. British Journal of Ophthalmology. 93 (4): 463–467. doi:10.1136/bjo.2008.138453. ISSNΒ 0007-1161.
  4. ↑ ChΓ©vez-Barrios, Patricia; Eagle, Ralph C.; Marback, Eduardo F. (2015). “Histopathologic Features and Prognostic Factors”: 167–183. doi:10.1007/978-3-662-43451-2_16.
  5. ↑ 5.0 5.1 5.2 Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW (1998). “Presenting signs of retinoblastoma”. J Pediatr. 132 (3 Pt 1): 505–8. PMIDΒ 9544909.
  6. ↑ Broaddus E, Topham A, Singh AD (2009). “Incidence of retinoblastoma in the USA: 1975-2004”. Br J Ophthalmol. 93 (1): 21–3. doi:10.1136/bjo.2008.138750. PMIDΒ 18621794.
  7. ↑ Binder PS (1974). “Unusual manifestations of retinoblastoma”. Am J Ophthalmol. 77 (5): 674–9. PMIDΒ 4132770.
  8. ↑ Zakka KA, Yee RD, Foos RY (1983). “Retinoblastoma in a 12-year-old girl”. Ann Ophthalmol. 15 (1): 88–91. PMIDΒ 6830100.
  9. ↑ Kaliki S, Shields CL, Gupta A, Mishra DK, Das C, Say EA, Shields JA (December 2015). “NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS”. Retina (Philadelphia, Pa.). 35 (12): 2483–8. doi:10.1097/IAE.0000000000000612. PMIDΒ 26035399.
  10. ↑ Singh, Arun (2007). Clinical ophthalmic oncology. Edinburgh: Elsevier Saunders. ISBNΒ 978-1-4160-3167-3.

​

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Simrat Sarai, M.D. [3]